Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Wasman Jane
Relationship:   Director
City:   Hawthorne
State:   NY
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   262,961    

Indirect Shares

   0      
Direct Value   $195,763    

Indirect Value

   $0      
Total Shares   262,961      
Total Value   $195,763      


Acorda Therapeutics Inc $58,945 Rigel Pharmaceuticals Inc $122,000 SELLAS Life Sciences Group Inc $14,664 Athersys Inc (New) $155 Acorda Therapeutics Inc $58,945 Rigel Pharmaceuticals Inc $122,000 SELLAS Life Sciences Group Inc $14,664 Athersys Inc (New) $155
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Acorda Therapeutics Inc ACOR President, Intl and GC 2019-12-02 117,420 0    Premium*  
            Rigel Pharmaceuticals Inc RIGL 2024-05-25 100,000 2021-05-19 0    Premium*  
            SELLAS Life Sciences Group Inc SLS Director 2024-01-22 10,400 2022-01-31 0    Premium*  
            Athersys Inc (New) ATHX Director 2023-01-09 35,141 2022-09-16 0    Premium*  
* Premium Members only  

Records found :    83         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ACOR Acorda Therapeutics Inc President, Intl and GC   •       –      –    2018-03-05 4 OE $19.81 $59,034 D/D 2,980 111,553 0 -
ACOR Acorda Therapeutics Inc President, Intl and GC   •       –      –    2018-12-03 4 AS $20.52 $62,947 D/D (3,067) 105,287 0 -
ACOR Acorda Therapeutics Inc President, Intl and GC   •       –      –    2015-12-17 4 OE $6.00 $19,662 D/D 3,277 112,673 0 -
ACOR Acorda Therapeutics Inc President, Intl and GC   •       –      –    2015-12-17 4 AS $40.00 $131,080 D/D (3,277) 109,396 0 -
ACOR Acorda Therapeutics Inc President, Intl and GC   •       –      –    2016-12-01 4 AS $20.72 $69,400 D/D (3,347) 101,674 0 -
ACOR Acorda Therapeutics Inc Exec VP, General Counsel & Sec   •       –      –    2008-06-11 4 S $31.50 $110,420 D/D (3,500) 26,164 0 -
ACOR Acorda Therapeutics Inc Exec VP, General Counsel & Sec   •       –      –    2008-06-11 4 OE $5.85 $20,475 D/D 3,500 29,664 0 -
ACOR Acorda Therapeutics Inc President, Intl and GC   •       –      –    2013-10-03 4 AS $35.74 $134,009 D/D (3,750) 105,459 0 -
ACOR Acorda Therapeutics Inc President, Intl and GC   •       –      –    2014-10-03 4 AS $34.13 $127,983 D/D (3,750) 101,534 0 -
ACOR Acorda Therapeutics Inc President, Intl and GC   •       –      –    2015-10-05 4 AS $30.91 $119,072 D/D (3,750) 98,097 0 -
ACOR Acorda Therapeutics Inc President, Intl and GC   •       –      –    2016-10-03 4 AS $20.78 $77,927 D/D (3,750) 105,021 0 -
ACOR Acorda Therapeutics Inc President, Intl and GC   •       –      –    2017-12-01 4 AS $20.52 $93,662 D/D (4,564) 102,110 0 -
ACOR Acorda Therapeutics Inc Exec VP, General Counsel & Sec   •       –      –    2006-11-10 4 AS $15.13 $73,612 D/D (4,851) 35,764 0 -
ACOR Acorda Therapeutics Inc Exec VP, General Counsel & Sec   •       –      –    2009-12-01 4 AS $24.50 $122,507 D/D (5,000) 33,664 0 -
ACOR Acorda Therapeutics Inc President, Intl and GC   •       –      –    2017-03-01 4 A $0.00 $0 D/D 5,000 106,674 0 -
ACOR Acorda Therapeutics Inc President, Intl and GC   •       –      –    2015-12-22 4 OE $5.85 $31,251 D/D 5,342 113,921 0 -
ACOR Acorda Therapeutics Inc President, Intl and GC   •       –      –    2015-12-01 4 AS $38.08 $210,294 D/D (5,523) 109,396 0 -
SLS SELLAS Life Sciences Grou... Director   –       •      –    2024-01-22 4 A $0.00 $0 D/D 6,000 10,400 0 -
ACOR Acorda Therapeutics Inc President, Intl and GC   •       –      –    2018-02-22 4 A $0.00 $0 D/D 6,463 108,573 0 -
ACOR Acorda Therapeutics Inc Exec VP, General Counsel & Sec   •       –      –    2006-11-07 4 AS $14.91 $102,197 D/D (6,700) 40,715 0 -
ACOR Acorda Therapeutics Inc President, Intl and GC   •       –      –    2014-12-01 4 AS $35.58 $247,471 D/D (6,956) 94,578 0 -
ACOR Acorda Therapeutics Inc President, Intl and GC   •       –      –    2012-12-03 4 AS $24.20 $169,868 D/D (7,019) 97,951 0 -
ACOR Acorda Therapeutics Inc President, Intl and GC   •       –      –    2015-03-04 4 A $0.00 $0 D/D 7,269 101,847 0 -
ACOR Acorda Therapeutics Inc Exec VP, General Counsel & Sec   •       –      –    2011-12-01 4 AS $22.92 $168,324 D/D (7,344) 57,570 0 -
ACOR Acorda Therapeutics Inc Exec VP, General Counsel & Sec   •       –      –    2010-12-01 4 AS $26.38 $198,994 D/D (7,500) 46,164 0 -
  83  Records found
  1   2  3   4      
  Page 2 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us